| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 40.034 | 26.350 | 28.059 | 26.064 | 28.635 | 33.793 | 50.272 | 53.752 | 51.234 | 42.254 |
| Total Income - EUR | 40.113 | 26.388 | 28.080 | 26.072 | 29.163 | 33.795 | 50.274 | 53.755 | 51.670 | 42.927 |
| Total Expenses - EUR | 32.302 | 32.837 | 37.490 | 34.346 | 39.484 | 38.324 | 38.508 | 41.688 | 48.267 | 53.225 |
| Gross Profit/Loss - EUR | 7.811 | -6.449 | -9.410 | -8.274 | -10.321 | -4.529 | 11.766 | 12.067 | 3.403 | -10.298 |
| Net Profit/Loss - EUR | 6.608 | -6.713 | -9.691 | -8.535 | -10.613 | -4.844 | 11.274 | 11.610 | 2.959 | -11.443 |
| Employees | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
Check the financial reports for the company - Dermatomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 11.425 | 8.837 | 7.915 | 7.756 | 7.261 | 6.862 | 8.943 | 9.831 | 9.091 | 8.335 |
| Current Assets | 79.207 | 74.004 | 63.917 | 59.746 | 44.578 | 41.757 | 46.043 | 57.044 | 62.079 | 51.237 |
| Inventories | 0 | 0 | 104 | 102 | 178 | 98 | 96 | 96 | 96 | 95 |
| Receivables | 48.443 | 48.440 | 46.740 | 46.871 | 32.631 | 24.139 | 24.762 | 23.816 | 26.103 | 18.887 |
| Cash | 30.763 | 25.564 | 17.073 | 12.773 | 11.769 | 17.520 | 21.185 | 33.132 | 35.880 | 32.255 |
| Shareholders Funds | 81.859 | 74.311 | 63.363 | 53.665 | 42.013 | 36.372 | 46.840 | 58.595 | 61.377 | 49.591 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 8.869 | 8.612 | 8.481 | 14.010 | 10.320 | 12.456 | 8.426 | 8.859 | 10.306 | 10.868 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dermatomed S.r.l.